Pharmaceutical Manufacturing Market Size, Share & Trends Analysis Report By Route of Administration, By Molecule Type, By Drug Development Type, By Sales Channel, By Age Group, By Formulation, By Region, And Segment Forecasts, 2023 - 2030

Table of Contents

Chapter 1. Pharmaceutical Manufacturing Market: Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Molecule Type
                        1.2.2. Drug Development Type
                        1.2.3. Formulation
                        1.2.4. Routes of Administration
                        1.2.5. Therapy Area
                        1.2.6. Prescription
                        1.2.7. Age Group
                        1.2.8. Sales Channel
                    1.3. Regional Scope
                    1.4. Estimates and Forecast Timeline
                    1.5. Research Methodology
                    1.6. Information Procurement
                        1.6.1. Purchased database
                        1.6.2. GVR's internal database
                        1.6.3. Secondary sources
                        1.6.4. Primary research
                        1.6.5. Details of primary research
                    1.7. Information or Data Analysis
                        1.7.1. Data analysis models
                    1.8. Market Formulation & Validation
                    1.9. Model Details
                            1.9.1.1. Commodity flow analysis (Model 1)
                            1.9.1.2. Approach 1: Commodity flow approach
                            1.9.1.3. Volume price analysis (Model 2)
                            1.9.1.4. Approach 2: Volume price analysis
                    1.10. List of Secondary Sources
                    1.11. List of Primary Sources
                    1.12. Objectives
                        1.12.1. Objective 1
                        1.12.2. Objective 2
Chapter 2. Pharmaceutical Manufacturing Market: Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                        2.2.1. Molecule Type outlook
                        2.2.2. Drug Development Type outlook
                        2.2.3. Formulation outlook
                        2.2.4. Route of Administration outlook
                        2.2.5. Therapy Area outlook
                        2.2.6. Prescription outlook
                        2.2.7. Age Group outlook
                        2.2.8. Sales Channel outlook
                        2.2.9. Regional outlook
                    2.3. Competitive Insights
Chapter 3. Pharmaceutical Manufacturing Market: Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Penetration & Growth Prospect Mapping
                    3.3. Market Dynamics
                        3.3.1. Market driver analysis
                            3.3.1.1. Rise in pharmaceutical R&D spending
                            3.3.1.2. Rise in focus toward healthcare needs in emerging nations
                            3.3.1.3. Technological advancements
                            3.3.1.4. Increase in geriatric population and incidence of chronic disorders
                        3.3.2. Market restraint analysis
                            3.3.2.1. Patent expiration of most profitable drugs
                            3.3.2.2. Pricing pressures on bio/pharmaceutical companies
                    3.4. Pharmaceutical manufacturing Market Analysis Tools
                        3.4.1. Industry Analysis - Porter's
                            3.4.1.1. Supplier power
                            3.4.1.2. Buyer power
                            3.4.1.3. Substitution threat
                            3.4.1.4. Threat of new entrant
                            3.4.1.5. Competitive rivalry
                        3.4.2. PESTEL Analysis
                            3.4.2.1. Political landscape
                            3.4.2.2. Technological landscape
                            3.4.2.3. Economic landscape
Chapter 4. Pharmaceutical Manufacturing: Molecule Type Estimates & Trend Analysis
                    4.1. Definitions and Scope
                        4.1.1. Biologics & Biosimilars (Large Molecules)
                        4.1.2. Conventional Drugs (Small Molecules)
                    4.2. Molecule Type Market Share, 2022 & 2030
                    4.3. Segment Dashboard
                    4.4. Global Pharmaceutical Manufacturing Market by Molecule Type Outlook
                    4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                        4.5.1. Biologics & Biosimilars (Large Molecules)
                            4.5.1.1. Biologics & Biosimilars (Large Molecules) market estimates and forecast 2018 to 2030 (USD Billion)
                            4.5.1.2. Monoclonal Antibodies
                                4.5.1.2.1. Monoclonal Antibodies market estimates and forecast 2018 to 2030 (USD Billion)
                            4.5.1.3. Vaccines
                                4.5.1.3.1. Vaccines market estimates and forecast 2018 to 2030 (USD Billion)
                            4.5.1.4. Cell & Gene Therapy
                                4.5.1.4.1. Cell & Gene Therapy market estimates and forecast 2018 to 2030 (USD Billion)
                            4.5.1.5. Others
                                4.5.1.5.1. Others market estimates and forecast 2018 to 2030 (USD Billion)
                        4.5.2. Conventional Drugs (Small Molecules)
                            4.5.2.1. Conventional Drugs (Small Molecules) market estimates and forecast 2018 to 2030 (USD Billion)
Chapter 5. Pharmaceutical Manufacturing: Drug Development Type Estimates & Trend Analysis
                    5.1. Definitions and Scope
                        5.1.1. In-house
                        5.1.2. Outsource
                    5.2. Drug Development Type Market Share, 2022 & 2030
                    5.3. Segment Dashboard
                    5.4. Global Microneedle Drug Delivery Systems Market by Drug Development Type Outlook
                    5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030for the following
                        5.5.1. In-house
                            5.5.1.1. In-house market estimates and forecast 2018 to 2030 (USD Billion)
                        5.5.2. Outsource
                            5.5.2.1. Outsource market estimates and forecast 2018 to 2030 (USD Billion)
Chapter 6. Pharmaceutical Manufacturing: Formulation Estimates & Trend Analysis
                    6.1. Definitions and Scope
                        6.1.1. Tablets
                        6.1.2. Capsules
                        6.1.3. Injectable
                        6.1.4. Sprays
                        6.1.5. Suspensions
                        6.1.6. Powders
                        6.1.7. Others
                    6.2. Formulation Market Share, 2022 & 2030
                    6.3. Segment Dashboard
                    6.4. Global Pharmaceutical Manufacturing Market by Formulation Outlook
                    6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                        6.5.1. Tablets
                            6.5.1.1. Tablets market estimates and forecast 2018 to 2030 (USD Billion)
                        6.5.2. Capsules
                            6.5.2.1. Capsules market estimates and forecast 2018 to 2030 (USD Billion)
                        6.5.3. Injectable
                            6.5.3.1. Injectable market estimates and forecast 2018 to 2030 (USD Billion)
                        6.5.4. Sprays
                            6.5.4.1. Sprays market estimates and forecast 2018 to 2030 (USD Billion)
                        6.5.5. Suspensions
                            6.5.5.1. Suspensions market estimates and forecast 2018 to 2030 (USD Billion)
                        6.5.6. Powders
                            6.5.6.1. Powders market estimates and forecast 2018 to 2030 (USD Billion)
                        6.5.7. Others
                            6.5.7.1. Others market estimates and forecast 2018 to 2030 (USD Billion)
Chapter 7. Pharmaceutical Manufacturing: Route of Administration Estimates & Trend Analysis
                    7.1. Definitions and Scope
                        7.1.1. Oral
                        7.1.2. Topical
                        7.1.3. Parenteral
                        7.1.4. Inhalations
                        7.1.5. Others
                    7.2. Route of Administration Market Share, 2022 & 2030
                    7.3. Segment Dashboard
                    7.4. Global Pharmaceutical Manufacturing Market by Route of Administration Outlook
                    7.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                        7.5.1. Oral
                            7.5.1.1. Oral market estimates and forecast 2018 to 2030 (USD Billion)
                        7.5.2. Topical
                            7.5.2.1. Topical market estimates and forecast 2018 to 2030 (USD Billion)
                        7.5.3. Parenteral
                            7.5.3.1. Parenteral market estimates and forecast 2018 to 2030 (USD Billion)
                        7.5.4. Inhalations
                            7.5.4.1. Inhalations market estimates and forecast 2018 to 2030 (USD Billion)
                        7.5.5. Others
                            7.5.5.1. Others market estimates and forecast 2018 to 2030 (USD Billion)
Chapter 8. Pharmaceutical Manufacturing: Therapy Area Estimates & Trend Analysis
                    8.1. Definitions and Scope
                        8.1.1. Cardiovascular diseases
                        8.1.2. Pain
                        8.1.3. Diabetes
                        8.1.4. Cancer
                        8.1.5. Respiratory diseases
                        8.1.6. Others
                    8.2. Therapy Area Market Share, 2022 & 2030
                    8.3. Segment Dashboard
                    8.4. Global Pharmaceutical Manufacturing Market by Therapy Area Outlook
                    8.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                        8.5.1. Cardiovascular diseases
                            8.5.1.1. Cardiovascular diseases market estimates and forecast 2018 to 2030 (USD Billion)
                        8.5.2. Pain
                            8.5.2.1. Pain market estimates and forecast 2018 to 2030 (USD Billion)
                        8.5.3. Diabetes
                            8.5.3.1. Diabetes market estimates and forecast 2018 to 2030 (USD Billion)
                        8.5.4. Cancer
                            8.5.4.1. Cancer market estimates and forecast 2018 to 2030 (USD Billion)
                        8.5.5. Respiratory diseases
                            8.5.5.1. Respiratory diseases market estimates and forecast 2018 to 2030 (USD Billion)
                        8.5.6. Others
                            8.5.6.1. Others market estimates and forecast 2018 to 2030 (USD Billion)
Chapter 9. Pharmaceutical Manufacturing: Prescription Estimates & Trend Analysis
                    9.1. Definitions and Scope
                        9.1.1. Prescription Medicines
                        9.1.2. Over-the-counter (OTC) medicines
                    9.2. Prescription Market Share, 2022 & 2030
                    9.3. Segment Dashboard
                    9.4. Global Pharmaceutical Manufacturing Market by Prescription Outlook
                    9.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                        9.5.1. Prescription Medicines
                            9.5.1.1. Prescription Medicines market estimates and forecast 2018 to 2030 (USD Billion)
                        9.5.2. Over-the-counter (OTC) medicines
                            9.5.2.1. Over-the-counter (OTC) medicines market estimates and forecast 2018 to 2030 (USD Billion)
Chapter 10. Pharmaceutical Manufacturing: Age Group Estimates & Trend Analysis
                    10.1. Definitions and Scope
                        10.1.1. Children & Adolescents
                        10.1.2. Adults
                        10.1.3. Geriatric
                    10.2. Age Group Market Share, 2022 & 2030
                    10.3. Segment Dashboard
                    10.4. Global Pharmaceutical Manufacturing Market by Age Group Outlook
                    10.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030for the following
                        10.5.1. Children & Adolescents
                            10.5.1.1. Children & Adolescents market estimates and forecast 2018 to 2030 (USD Billion)
                        10.5.2. Adults
                            10.5.2.1. Adults market estimates and forecast 2018 to 2030 (USD Billion)
                        10.5.3. Geriatric
                            10.5.3.1. Geriatric market estimates and forecast 2018 to 2030 (USD Billion)
Chapter 11. Pharmaceutical Manufacturing: Sales Channel Estimates & Trend Analysis
                    11.1. Definitions and Scope
                        11.1.1. Retail
                        11.1.2. Non-retail
                    11.2. Sales Channel Market Share, 2022 & 2030
                    11.3. Segment Dashboard
                    11.4. Global Pharmaceutical Manufacturing Market by Sales Channel Outlook
                    11.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                        11.5.1. Retail
                            11.5.1.1. Retail market estimates and forecast 2018 to 2030 (USD Billion)
                        11.5.2. Non-retail
                            11.5.2.1. Non-retail market estimates and forecast 2018 to 2030 (USD Billion)
Chapter 12. Pharmaceutical Manufacturing Market: Regional Estimates & Trend Analysis
                    12.1. Regional market share analysis, 2022 & 2030
                    12.2. Regional Market Dashboard
                    12.3. Global Regional Market Snapshot
                    12.4. Regional Market Share and Leading Players, 2021
                        12.4.1. North America
                        12.4.2. Europe
                        12.4.3. Asia Pacific
                        12.4.4. Latin America
                        12.4.5. Middle East and Africa
                    12.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
                        12.5.1. North America
                        12.5.2. Europe
                        12.5.3. Asia Pacific
                        12.5.4. Latin America
                        12.5.5. Middle East and Africa
                    12.6. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2030:
                    12.7. North America
                        12.7.1. SWOT Analysis
                        12.7.2. North America Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
                        12.7.3. U.S.
                            12.7.3.1. Key Country Dynamics
                            12.7.3.2. Target Disease Prevalence
                            12.7.3.3. Competitive Scenario
                            12.7.3.4. Regulatory Framework
                            12.7.3.5. U.S. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
                        12.7.4. Canada
                            12.7.4.1. Key Country Dynamics
                            12.7.4.2. Target Disease Prevalence
                            12.7.4.3. Competitive Scenario
                            12.7.4.4. Regulatory Framework
                            12.7.4.5. Canada Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
                    12.8. Europe
                        12.8.1. SWOT Analysis
                        12.8.2. Europe Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
                        12.8.3. UK
                            12.8.3.1. Key Country Dynamics
                            12.8.3.2. Target Disease Prevalence
                            12.8.3.3. Competitive Scenario
                            12.8.3.4. Regulatory Framework
                            12.8.3.5. UK Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
                        12.8.4. Germany
                            12.8.4.1. Key Country Dynamics
                            12.8.4.2. Target Disease Prevalence
                            12.8.4.3. Competitive Scenario
                            12.8.4.4. Regulatory Framework
                            12.8.4.5. Germany Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
                        12.8.5. France
                            12.8.5.1. Key Country Dynamics
                            12.8.5.2. Target Disease Prevalence
                            12.8.5.3. Competitive Scenario
                            12.8.5.4. Regulatory Framework
                            12.8.5.5. France Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
                        12.8.6. Italy
                            12.8.6.1. Key Country Dynamics
                            12.8.6.2. Target Disease Prevalence
                            12.8.6.3. Competitive Scenario
                            12.8.6.4. Regulatory Framework
                            12.8.6.5. Italy Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
                        12.8.7. Spain
                            12.8.7.1. Key Country Dynamics
                            12.8.7.2. Target Disease Prevalence
                            12.8.7.3. Competitive Scenario
                            12.8.7.4. Regulatory Framework
                            12.8.7.5. Spain Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
                        12.8.8. Denmark
                            12.8.8.1. Key Country Dynamics
                            12.8.8.2. Target Disease Prevalence
                            12.8.8.3. Competitive Scenario
                            12.8.8.4. Regulatory Framework
                            12.8.8.5. Denmark Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
                        12.8.9. Sweden
                            12.8.9.1. Key Country Dynamics
                            12.8.9.2. Target Disease Prevalence
                            12.8.9.3. Competitive Scenario
                            12.8.9.4. Regulatory Framework
                            12.8.9.5. Sweden Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
                        12.8.10. Norway
                            12.8.10.1. Key Country Dynamics
                            12.8.10.2. Target Disease Prevalence
                            12.8.10.3. Competitive Scenario
                            12.8.10.4. Regulatory Framework
                            12.8.10.5. Norway Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
                    12.9. Asia Pacific
                        12.9.1. SWOT Analysis
                        12.9.2. Asia Pacific Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
                        12.9.3. China
                            12.9.3.1. Key Country Dynamics
                            12.9.3.2. Target Disease Prevalence
                            12.9.3.3. Competitive Scenario
                            12.9.3.4. Regulatory Framework
                            12.9.3.5. China Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
                        12.9.4. Japan
                            12.9.4.1. Key Country Dynamics
                            12.9.4.2. Target Disease Prevalence
                            12.9.4.3. Competitive Scenario
                            12.9.4.4. Regulatory Framework
                            12.9.4.5. Japan Market estimates and forecast, 2018 - 2030 (Volume, Thousand)
                        12.9.5. India
                            12.9.5.1. Key Country Dynamics
                            12.9.5.2. Target Disease Prevalence
                            12.9.5.3. Competitive Scenario
                            12.9.5.4. Regulatory Framework
                            12.9.5.5. India Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
                        12.9.6. Australia
                            12.9.6.1. Key Country Dynamics
                            12.9.6.2. Target Disease Prevalence
                            12.9.6.3. Competitive Scenario
                            12.9.6.4. Regulatory Framework
                            12.9.6.5. Australia Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
                        12.9.7. Thailand
                            12.9.7.1. Key Country Dynamics
                            12.9.7.2. Target Disease Prevalence
                            12.9.7.3. Competitive Scenario
                            12.9.7.4. Regulatory Framework
                            12.9.7.5. Thailand Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
                        12.9.8. South Korea
                            12.9.8.1. Key Country Dynamics
                            12.9.8.2. Target Disease Prevalence
                            12.9.8.3. Competitive Scenario
                            12.9.8.4. Regulatory Framework
                            12.9.8.5. South Korea Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
                    12.10. Latin America
                        12.10.1. SWOT Analysis
                        12.10.2. Latin America Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
                        12.10.3. Brazil
                            12.10.3.1. Key Country Dynamics
                            12.10.3.2. Target Disease Prevalence
                            12.10.3.3. Competitive Scenario
                            12.10.3.4. Regulatory Framework
                            12.10.3.5. Brazil Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
                        12.10.4. Mexico
                            12.10.4.1. Key Country Dynamics
                            12.10.4.2. Target Disease Prevalence
                            12.10.4.3. Competitive Scenario
                            12.10.4.4. Regulatory Framework
                            12.10.4.5. Mexico Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
                        12.10.5. Argentina
                            12.10.5.1. Key Country Dynamics
                            12.10.5.2. Target Disease Prevalence
                            12.10.5.3. Competitive Scenario
                            12.10.5.4. Regulatory Framework
                            12.10.5.5. Argentina Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
                    12.11. MEA
                        12.11.1. SWOT Analysis
                        12.11.2. MEA Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
                        12.11.3. Saudi Arabia
                            12.11.3.1. Key Country Dynamics
                            12.11.3.2. Target Disease Prevalence
                            12.11.3.3. Competitive Scenario
                            12.11.3.4. Regulatory Framework
                            12.11.3.5. Saudi Arabia Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
                        12.11.4. South Africa
                            12.11.4.1. Key Country Dynamics
                            12.11.4.2. Target Disease Prevalence
                            12.11.4.3. Competitive Scenario
                            12.11.4.4. Regulatory Framework
                            12.11.4.5. South Africa Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
                        12.11.5. UAE
                            12.11.5.1. Key Country Dynamics
                            12.11.5.2. Target Disease Prevalence
                            12.11.5.3. Competitive Scenario
                            12.11.5.4. Regulatory Framework
                            12.11.5.5. UAE Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
                        12.11.6. Kuwait
                            12.11.6.1. Key Country Dynamics
                            12.11.6.2. Target Disease Prevalence
                            12.11.6.3. Competitive Scenario
                            12.11.6.4. Regulatory Framework
                            12.11.6.5. Kuwait Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
Chapter 13. Competitive Landscape
                    13.1. Recent Developments & Impact Analysis, By Key Market Participants
                    13.2. Company/Competition Categorization
                        13.2.1. Innovators
                    13.3. Vendor Landscape
                        13.3.1. List of key distributors and channel partners
                        13.3.2. Key customers
                        13.3.3. Key company market share analysis, 2022
                            13.3.4. F. Hoffmann-La Roche Ltd.
                            13.3.4.1. Company overview
                            13.3.4.2. Financial performance
                            13.3.4.3. Product benchmarking
                            13.3.4.4. Strategic initiatives
                        13.3.5. Novartis AG
                            13.3.5.1. Company overview
                            13.3.5.2. Financial performance
                            13.3.5.3. Product benchmarking
                            13.3.5.4. Strategic initiatives
                        13.3.6. GlaxoSmithKline plc
                            13.3.6.1. Company overview
                            13.3.6.2. Financial performance
                            13.3.6.3. Product benchmarking
                            13.3.6.4. Strategic initiatives
                        13.3.7. Pfizer, Inc.
                            13.3.7.1. Company overview
                            13.3.7.2. Financial performance
                            13.3.7.3. Product benchmarking
                            13.3.7.4. Strategic initiatives
                        13.3.8. Merck & Co., Inc.
                            13.3.8.1. Company overview
                            13.3.8.2. Financial performance
                            13.3.8.3. Product benchmarking
                            13.3.8.4. Strategic initiatives
                        13.3.9. AstraZeneca
                            13.3.9.1. Company overview
                            13.3.9.2. Financial performance
                            13.3.9.3. Product benchmarking
                            13.3.9.4. Strategic initiatives
                        13.3.10. Johnson & Johnson Services, Inc.
                            13.3.10.1. Company overview
                            13.3.10.2. Financial performance
                            13.3.10.3. Product benchmarking
                            13.3.10.4. Strategic initiatives
                        13.3.11. Sanofi SA
                            13.3.11.1. Company overview
                            13.3.11.2. Financial performance
                            13.3.11.3. Product benchmarking
                            13.3.11.4. Strategic initiatives
                        13.3.12. Eli Lilly and Company
                            13.3.12.1. Company overview
                            13.3.12.2. Financial performance
                            13.3.12.3. Product benchmarking
                            13.3.12.4. Strategic initiatives
                        13.3.13. AbbVie, Inc.
                            13.3.13.1. Company overview
                            13.3.13.2. Financial performance
                            13.3.13.3. Product benchmarking
                            13.3.13.4. Strategic initiatives
                        13.3.14. Thermo Fisher Scientific, Inc.
                            13.3.14.1. Company overview
                            13.3.14.2. Financial performance
                            13.3.14.3. Product benchmarking
                            13.3.14.4. Strategic initiatives
                        13.3.15. Wuxi Apptec
                            13.3.15.1. Company overview
                            13.3.15.2. Financial performance
                            13.3.15.3. Product benchmarking
                            13.3.15.4. Strategic initiatives
                        13.3.16. Samsung Biologics
                            13.3.16.1. Company overview
                            13.3.16.2. Financial performance
                            13.3.16.3. Product benchmarking
                            13.3.16.4. Strategic initiatives
                        13.3.17. FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
                            13.3.17.1. Company overview
                            13.3.17.2. Financial performance
                            13.3.17.3. Product benchmarking
                            13.3.17.4. Strategic initiatives
                        13.3.18. Lonza
                            13.3.18.1. Company overview
                            13.3.18.2. Financial performance
                            13.3.18.3. Product benchmarking
                            13.3.18.4. Strategic initiatives
                        13.3.19. Catalent Pharma Solutions
                            13.3.19.1. Company overview
                            13.3.19.2. Financial performance
                            13.3.19.3. Product benchmarking
                            13.3.19.4. Strategic initiatives
                        13.3.20. Jubilant Pharmova Limited
                            13.3.20.1. Company overview
                            13.3.20.2. Financial performance
                            13.3.20.3. Product benchmarking
                            13.3.20.4. Strategic initiatives

List of Tables

Table 1 List of Abbreviation
Table 2 Global pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 3 Global pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 4 Global pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 5 Global pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 6 Global pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 7 Global pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 8 Global pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 9 Global pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 10 Global pharmaceutical manufacturing market, by region, 2018 - 2030 (USD Billion)
Table 11 North America pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 12 North America pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 13 North America pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 14 North America pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 15 North America pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 16 North America pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 17 North America pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 18 North America pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 19 U.S. pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 20 U.S. pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 21 U.S. pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 22 U.S. pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 23 U.S. pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 24 U.S. pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 25 U.S. pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 26 U.S. pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 27 Canada pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 28 Canada pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 29 Canada pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 30 Canada pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 31 Canada pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 32 Canada pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 33 Canada pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 34 Canada pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 35 Europe pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 36 Europe pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 37 Europe pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 38 Europe pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 39 Europe pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 40 Europe pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 41 Europe pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 42 Europe pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 43 Germany pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 44 Germany pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 45 Germany pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 46 Germany pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 47 Germany pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 48 Germany pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 49 Germany pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 50 Germany pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 51 UK pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 52 UK pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 53 UK pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 54 UK pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 55 UK pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 56 UK pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 57 UK pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 58 UK pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 59 France pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 60 France pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 61 France pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 62 France pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 63 France pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 64 France pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 65 France pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 66 France pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 67 Italy pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 68 Italy pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 69 Italy pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 70 Italy pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 71 Italy pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 72 Italy pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 73 Italy pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 74 Italy pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 75 Spain pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 76 Spain pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 77 Spain pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 78 Spain pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 79 Spain pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 80 Spain pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 81 Spain pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 82 Spain pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 83 Sweden pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 84 Sweden pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 85 Sweden pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 86 Sweden pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 87 Sweden pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 88 Sweden pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 89 Sweden pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 90 Sweden pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 91 Norway pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 92 Norway pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 93 Norway pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 94 Norway pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 95 Norway pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 96 Norway pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 97 Norway pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 98 Norway pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 99 Denmark pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 100 Denmark pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 101 Denmark pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 102 Denmark pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 103 Denmark pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 104 Denmark pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 105 Denmark pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 106 Denmark pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 107 Asia Pacific pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 108 Asia Pacific pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 109 Asia Pacific pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 110 Asia Pacific pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 111 Asia Pacific pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 112 Asia Pacific pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 113 Asia Pacific pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 114 Asia Pacific pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 115 China pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 116 China pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 117 China pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 118 China pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 119 China pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 120 China pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 121 China pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 122 China pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 123 Japan pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 124 Japan pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 125 Japan pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 126 Japan pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 127 Japan pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 128 Japan pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 129 Japan pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 130 Japan pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 131 India pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 132 India pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 133 India pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 134 India pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 135 India pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 136 India pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 137 India pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 138 India pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 139 Thailand pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 140 Thailand pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 141 Thailand pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 142 Thailand pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 143 Thailand pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 144 Thailand pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 145 Thailand pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 146 Thailand pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 147 South Korea pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 148 South Korea pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 149 South Korea pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 150 South Korea pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 151 South Korea pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 152 South Korea pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 153 South Korea pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 154 South Korea pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 155 Australia pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 156 Australia pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 157 Australia pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 158 Australia pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 159 Australia pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 160 Australia pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 161 Australia pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 162 Australia pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 163 Latin America pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 164 Latin America pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 165 Latin America pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 166 Latin America pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 167 Latin America pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 168 Latin America pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 169 Latin America pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 170 Latin America pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 171 Brazil pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 172 Brazil pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 173 Brazil pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 174 Brazil pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 175 Brazil pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 176 Brazil pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 177 Brazil pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 178 Brazil pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 179 Mexico pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 180 Mexico pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 181 Mexico pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 182 Mexico pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 183 Mexico pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 184 Mexico pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 185 Mexico pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 186 Mexico pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 187 Argentina pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 188 Argentina pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 189 Argentina pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 190 Argentina pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 191 Argentina pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 192 Argentina pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 193 Argentina pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 194 Argentina pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 195 Middle East and Africa pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 196 Middle East and Africa pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 197 Middle East and Africa pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 198 Middle East and Africa pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 199 Middle East and Africa pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 200 Middle East and Africa pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 201 Middle East and Africa pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 202 Middle East and Africa pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 203 South Africa pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 204 South Africa pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 205 South Africa pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 206 South Africa pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 207 South Africa pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 208 South Africa pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 209 South Africa pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 210 South Africa pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 211 Saudi Arabia pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 212 Saudi Arabia pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 213 Saudi Arabia pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 214 Saudi Arabia pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 215 Saudi Arabia pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 216 Saudi Arabia pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 217 Saudi Arabia pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 218 Saudi Arabia pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 219 UAE pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 220 UAE pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 221 UAE pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 222 UAE pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 223 UAE pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 224 UAE pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 225 UAE pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 226 UAE pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
Table 227 Kuwait pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
Table 228 Kuwait pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
Table 229 Kuwait pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
Table 230 Kuwait pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
Table 231 Kuwait pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
Table 232 Kuwait pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
Table 233 Kuwait pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
Table 234 Kuwait pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Pharmaceutical manufacturing: market outlook
Fig. 9 Pharmaceutical manufacturing competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Pharmaceutical manufacturing market driver impact
Fig. 15 Pharmaceutical manufacturing market restraint impact
Fig. 16 Pharmaceutical manufacturing market strategic initiatives analysis
Fig. 17 Pharmaceutical manufacturing market: molecule type movement analysis
Fig. 18 Pharmaceutical manufacturing market: molecule type outlook and key takeaways
Fig. 19 Large molecules market estimates and forecast, 2018 - 2030
Fig. 20 Monoclonal Antibodies market estimates and forecast, 2018 - 2030
Fig. 21 Vaccines market estimates and forecast, 2018 - 2030
Fig. 22 Cell & Gene Therapy market estimates and forecast, 2018 - 2030
Fig. 23 Others market estimates and forecast, 2018 - 2030
Fig. 24 Small molecules market estimates and forecast, 2018 - 2030
Fig. 25 Pharmaceutical manufacturing market: drug development type movement analysis
Fig. 26 Pharmaceutical manufacturing market: drug development type outlook and key takeaways
Fig. 27 Outsource market estimates and forecast, 2018 - 2030
Fig. 28 In-house market estimates and forecast, 2018 - 2030
Fig. 29 Pharmaceutical manufacturing market: formulation movement analysis
Fig. 30 Pharmaceutical manufacturing market: formulation outlook and key takeaways
Fig. 31 Tablets market estimates and forecast, 2018 - 2030
Fig. 32 Capsules market estimates and forecast, 2018 - 2030
Fig. 33 Injectable market estimates and forecast, 2018 - 2030
Fig. 34 Sprays market estimates and forecast, 2018 - 2030
Fig. 35 Suspensions market estimates and forecast, 2018 - 2030
Fig. 36 Powders market estimates and forecast, 2018 - 2030
Fig. 37 Others market estimates and forecast, 2018 - 2030
Fig. 38 Pharmaceutical manufacturing market: route of administration movement analysis
Fig. 39 Pharmaceutical manufacturing market: route of administration outlook and key takeaways
Fig. 40 Oral market estimates and forecast, 2018 - 2030
Fig. 41 Topical market estimates and forecast, 2018 - 2030
Fig. 42 Parenteral market estimates and forecast, 2018 - 2030
Fig. 43 Inhalation market estimates and forecast, 2018 - 2030
Fig. 44 Others market estimates and forecast, 2018 - 2030
Fig. 45 Pharmaceutical manufacturing market: Therapy area movement analysis
Fig. 46 Pharmaceutical manufacturing market: Therapy Area outlook and key takeaways
Fig. 47 CVDs market estimates and forecast, 2018 - 2030
Fig. 48 Pain market estimates and forecast, 2018 - 2030
Fig. 49 Diabetes management market estimates and forecast, 2018 - 2030
Fig. 50 Cancer market estimates and forecast, 2018 - 2030
Fig. 51 Respiratory diseases market estimates and forecast, 2018 - 2030
Fig. 52 Others market estimates and forecast, 2018 - 2030
Fig. 53 Pharmaceutical manufacturing market: prescription movement analysis
Fig. 54 Pharmaceutical manufacturing market: prescription outlook and key takeaways
Fig. 55 Prescription medicines market estimates and forecast, 2018 - 2030
Fig. 56 Over-the-counter medicines market estimates and forecast, 2018 - 2030
Fig. 57 Pharmaceutical manufacturing market: age-group movement analysis
Fig. 58 Pharmaceutical manufacturing market: age-group outlook and key takeaways
Fig. 59 Children & Adolescents market estimates and forecast, 2018 - 2030
Fig. 60 Adults market estimates and forecast, 2018 - 2030
Fig. 61 Geriatric market estimates and forecast, 2018 - 2030
Fig. 62 Pharmaceutical manufacturing market: sales channel movement analysis
Fig. 63 Pharmaceutical manufacturing market: sales channel outlook and key takeaways
Fig. 64 Retail market estimates and forecast, 2018 - 2030
Fig. 65 Non-Retail market estimates and forecast, 2018 - 2030
Fig. 66 Global Pharmaceutical manufacturing market: regional movement analysis
Fig. 67 Global Pharmaceutical manufacturing market: regional outlook and key takeaways
Fig. 68 Global market share and leading players
Fig. 69 North America market share and leading players
Fig. 70 Europe market share and leading players
Fig. 71 Asia Pacific market share and leading players
Fig. 72 Latin America market share and leading players
Fig. 73 Middle East & Africa market share and leading players
Fig. 74 North America: SWOT
Fig. 75 Europe SWOT
Fig. 76 Asia Pacific SWOT
Fig. 77 Latin America SWOT
Fig. 78 MEA SWOT
Fig. 79 North America, by country
Fig. 80 North America
Fig. 81 North America market estimates and forecast, 2018 - 2030
Fig. 82 U.S. Key Country Dynamics
Fig. 83 U.S. market estimates and forecast, 2018 - 2030
Fig. 84 Canada Key Country Dynamics
Fig. 85 Canada market estimates and forecast, 2018 - 2030
Fig. 86 Europe
Fig. 87 Europe. market estimates and forecast, 2018 - 2030
Fig. 88 UK Key Country Dynamics
Fig. 89 UK market estimates and forecast, 2018 - 2030
Fig. 90 Germany Key Country Dynamics
Fig. 91 Germany market estimates and forecast, 2018 - 2030
Fig. 92 France Key Country Dynamics
Fig. 93 France market estimates and forecast, 2018 - 2030
Fig. 94 Italy Key Country Dynamics
Fig. 95 Italy market estimates and forecast, 2018 - 2030
Fig. 96 Spain Key Country Dynamics
Fig. 97 Spain market estimates and forecast, 2018 - 2030
Fig. 98 Sweden Key Country Dynamics
Fig. 99 Sweden market estimates and forecast, 2018 - 2030
Fig. 100 Norway Key Country Dynamics
Fig. 101 Norway market estimates and forecast, 2018 - 2030
Fig. 102 Denmark Key Country Dynamics
Fig. 103 Denmark market estimates and forecast, 2018 - 2030
Fig. 104 Asia Pacific Key Country Dynamics
Fig. 105 Asia Pacific market estimates and forecast, 2018 - 2030
Fig. 106 China Key Country Dynamics
Fig. 107 China market estimates and forecast, 2018 - 2030
Fig. 108 Japan Key Country Dynamics
Fig. 109 Japan market estimates and forecast, 2018 - 2030
Fig. 110 India Key Country Dynamics
Fig. 111 India market estimates and forecast, 2018 - 2030
Fig. 112 Australia Key Country Dynamics
Fig. 113 Australia market estimates and forecast, 2018 - 2030
Fig. 114 Thailand Key Country Dynamics
Fig. 115 Thailand market estimates and forecast, 2018 - 2030
Fig. 116 South Korea Key Country Dynamics
Fig. 117 South Korea market estimates and forecast, 2018 - 2030
Fig. 118 Latin America
Fig. 119 Latin America market estimates and forecast, 2018 - 2030
Fig. 120 Brazil Key Country Dynamics
Fig. 121 Brazil market estimates and forecast, 2018 - 2030
Fig. 122 Mexico Key Country Dynamics
Fig. 123 Mexico market estimates and forecast, 2018 - 2030
Fig. 124 Argentina Key Country Dynamics
Fig. 125 Argentina market estimates and forecast, 2018 - 2030
Fig. 126 Middle East and Africa
Fig. 127 Middle East and Africa. market estimates and forecast, 2018 - 2030
Fig. 128 Saudi Arabia Key Country Dynamics
Fig. 129 Saudi Arabia market estimates and forecast, 2018 - 2030
Fig. 130 South Africa Key Country Dynamics
Fig. 131 South Africa market estimates and forecast, 2018 - 2030
Fig. 132 UAE Key Country Dynamics
Fig. 133 UAE market estimates and forecast, 2018 - 2030
Fig. 134 Kuwait Key Country Dynamics
Fig. 135 Kuwait market estimates and forecast, 2018 - 2030
Fig. 136 Participant categorization - Pharmaceutical manufacturing market
Fig. 137 Market share of key market players - Pharmaceutical manufacturing market